๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Protein glycosylation in diabetes mellitus: biochemical and clinical considerations

โœ Scribed by Stanaway, S.E.R.S. ;Gill, G.V.

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
250 KB
Volume
17
Category
Article
ISSN
1357-8170

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Advanced glycosylation end products (AGE
Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with Type 2 diabetes mellitus
โœ Ma. Eugenia Garay-Sevilla; Laura Eugenia Nava; Juan Manuel Malacara; Kazimierz W ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 126 KB ๐Ÿ‘ 1 views

Background Advanced glycosylation end product (AGE) formation is a major mechanism for the development of complications in diabetes, and the possible roles of insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) are not clearly established. ## Methods We examined the associati

Clinical characterization of polymorphis
Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with Type 2 diabetes mellitus
โœ Ishiyama-Shigemoto, S.; Yamada, K.; Yuan, X.; Koyama, W.; Nonaka, K. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 70 KB ๐Ÿ‘ 2 views

To assess the association of polymorphisms at the sulphonylurea receptor (SUR1) gene with the development of Type 2 diabetes mellitus, 456 subjects, 236 with Type 2 diabetes and 220 non-diabetic controls, were analysed for variants at exon 7, exon 22 and intron 24 of the SUR1 gene by the polymerase